Skip to main content

FDA Approvals

Drugs in Phase 3 Clinical Trials for Type 2 Diabetes

Novel Approaches to Therapy in the Oncology Pipeline

Caroline Helwick

FDA Approvals, Original Research

Strategies to Prevent Opioid Misuse, Abuse, and Diversion That May Also Reduce the Associated Costs

Kathryn L. Hahn, PharmD, DAAPM, CPE

Stakeholder Perspective

Just Say No

by Atheer A. Kaddis, PharmD

Promising Oncology Drugs in the Pipeline

Caroline Helwick

FDA Approvals, Perspectives

Wayne Kuznar, Nirav R. Shah, MD,MPH, F. Randy Vogenberg, PhD, FASHP

Regulatory Concerns Fuel Hunger in Congress for FDA Reform

Behind-the-Counter Drug Access

Approvable Letters in 2007 and the Outlook for 2008

Heparin at the Center of the Storm

Potayto—Potahto? The Meaning of the FDA's "Complete Response" Letters

Page 52 of 53
Results 511 - 520 of 528